JP Morgan Private Wealth Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$614K Sell
14,014
-981
-7% -$47.9K ﹤0.01% 1159
2023
Q2
$740K Sell
14,995
-6,044
-29% -$279K ﹤0.01% 875
2023
Q1
$872K Sell
21,039
-207
-1% -$8.59K ﹤0.01% 1228
2022
Q4
$943K Sell
21,246
-3,567
-14% -$149K ﹤0.01% 1174
2022
Q3
$970K Sell
24,813
-2,877
-10% -$132K ﹤0.01% 1149
2022
Q2
$1.13M Buy
27,690
+2,201
+9% +$104K ﹤0.01% 1079
2022
Q1
$1.67M Sell
25,489
-6,177
-20% -$400K ﹤0.01% 971
2021
Q4
$2.2M Sell
31,666
-782
-2% -$56.8K ﹤0.01% 870
2021
Q3
$2.26M Buy
32,448
+783
+2% +$60.3K 0.01% 847
2021
Q2
$2.51M Buy
31,665
+17,352
+121% +$1.26M 0.01% 794
2021
Q1
$938K Sell
14,313
-7,401
-34% -$456K ﹤0.01% 1070
2020
Q4
$1.21M Buy
21,714
+13,368
+160% +$578K ﹤0.01% 932
2020
Q3
$333K Buy
8,346
+3,165
+61% +$134K ﹤0.01% 1315
2020
Q2
$233K Buy
+5,181
New +$226K ﹤0.01% 1406

Other funds holding ATRC

JP Morgan Private Wealth Advisors's ATRC Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its AtriCure (ATRC) stake by 6.5% in Q3 2023, selling an estimated $47.9K and leaving 14,014 shares worth $614K. The position accounts for ﹤0.01% of the portfolio, ranked #1159.

JP Morgan Private Wealth Advisors first reported a position in ATRC in Q2 2020 and has held it in 14 quarters since. The position peaked at $2.51M in Q2 2021. 230 funds tracked by Wall St. Rank hold ATRC as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 14,014 shares of AtriCure worth $614K as of Q3 2023.
  • JP Morgan Private Wealth Advisors sold 981 AtriCure shares in Q3 2023, an estimated $47.9K.
  • AtriCure made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1159 holding.
  • JP Morgan Private Wealth Advisors first reported a position in AtriCure in Q2 2020 and has held it in 14 quarters since.
  • JP Morgan Private Wealth Advisors's AtriCure position peaked at $2.51M in Q2 2021.
  • 230 funds tracked by Wall St. Rank held AtriCure as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.